SUSAN PEAROSE: Open Payments
NPI 1972137453 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,095 in 97 payments from 26 companies in 2025. Trend: 2023 $842 · 2024 $672 · 2025 $2,095
Food & beverage: $2,009Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $305 |
| Janssen Biotech, Inc. | 14 | $280 |
| Arcutis Biotherapeutics, Inc. | 4 | $185 |
| PFIZER INC. | 6 | $184 |
| Regeneron Healthcare Solutions, Inc. | 14 | $161 |
| GENZYME CORPORATION | 5 | $149 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| Amgen Inc. | 4 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
Products named: DUPIXENT, TREMFYA, Zoryve, CIBINQO, RINVOQ, SKYRIZI, Winlevi, Otezla.
Industry payments across CA — which companies pay providers there.
